An activating Fgfr3 mutation affects trabecular bone formation via a paracrine mechanism during growth

Human Molecular Genetics

Volumn 21, Issue 11, 2012, Pages 2503-2513

  Mugniery, Emilie ^a   Dacquin, Romain ^b   Marty, Caroline ^a   Benoist Lasselin, Catherine ^a   de Vernejoul, Marie Christine ^a   Jurdic, Pierre ^b   Munnich, Arnold ^a   Geoffroy, Valérie ^a   Legeai Mallet, Laurence ^a  

^a INSERM   (France)

^b UNIVERSITÉ DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARTILAGE; CARTILAGE CELL; CARTILAGE MATRIX; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DWARFISM; GENE MUTATION; GROWTH PLATE; MALE; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CELL PROLIFERATION; CHONDROCYTES; GROWTH PLATE; MICE; MICE, TRANSGENIC; MUTATION; OSTEOBLASTS; OSTEOGENESIS; PARACRINE COMMUNICATION; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3;

MUS;

EID: 84861122894     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/dds065     Document Type: Article

References (49)

1. Ornitz, D.M. and Marie, P.J. (2002) FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev., 16, 1446-1465.
2. Baujat, G., Legeai-Mallet, L., Finidori, G., Cormier-Daire, V. and Le Merrer, M. (2008) Achondroplasia. Best Pract. Res. Clin. Rheumatol., 22, 3-18.
3. Rousseau, F., Bonaventure, J., Legeai-Mallet, L., Pelet, A., Rozet, J.M., Maroteaux, P., Le Merrer, M. and Munnich, A. (1994) Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature, 371, 252-254.
4. Horton, W.A., Hall, J.G. and Hecht, J.T. (2007) Achondroplasia. Lancet, 370, 162-172.
5. Shiang, R., Thompson, L.M., Zhu, Y.Z., Church, D.M., Fielder, T.J., Bocian, M., Winokur, S.T. and Wasmuth, J.J. (1994) Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell, 78, 335-342.
6. Bellus, G.A., McIntosh, I., Smith, E.A., Aylsworth, A.S., Kaitila, I., Horton, W.A., Greenhaw, G.A., Hecht, J.T. and Francomano, C.A. (1995) A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia. Nat. Genet., 10, 357-359.
7. Rousseau, F., el Ghouzzi, V., Delezoide, A.L., Legeai-Mallet, L., Le Merrer, M., Munnich, A. and Bonaventure, J. (1996) Missense FGFR3 mutations create cysteine residues in thanatophoric dwarfism type I (TD1). Hum. Mol. Genet., 5, 509-512.
8. Muenke, M., Gripp, K.W., McDonald-McGinn, D.M., Gaudenz, K., Whitaker, L.A., Bartlett, S.P., Markowitz, R.I., Robin, N.H., Nwokoro, N., Mulvihill, J.J. et al. (1997) A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome. Am. J. Hum. Genet., 60, 555-564.
9. Meyers, G.A., Orlow, S.J., Munro, I.R., Przylepa, K.A. and Jabs, E.W. (1995) Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans. Nat. Genet., 11, 462-464.
10. Olsen, B.R., Reginato, A.M. and Wang, W. (2000) Bone development. Annu. Rev. Cell Dev. Biol., 16, 191-220.
11. Gerber, H.P., Vu, T.H., Ryan, A.M., Kowalski, J., Werb, Z. and Ferrara, N. (1999) VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat. Med., 5, 623-628.
12. Johansson, N., Saarialho-Kere, U., Airola, K., Herva, R., Nissinen, L., Westermarck, J., Vuorio, E., Heino, J. and Kahari, V.M. (1997) Collagenase-3 (MMP-13) is expressed by hypertrophic chondrocytes, periosteal cells, and osteoblasts during human fetal bone development. Dev. Dyn., 208, 387-397.
13. Inada, M., Wang, Y., Byrne, M.H., Rahman, M.U., Miyaura, C., Lopez-Otin, C. and Krane, S.M. (2004) Critical roles for collagenase-3 (Mmp13) in development of growth plate cartilage and in endochondral ossification. Proc. Natl Acad. Sci. USA, 101, 17192-17197.
14. Engsig, M.T., Chen, Q.J., Vu, T.H., Pedersen, A.C., Therkidsen, B., Lund, L.R., Henriksen, K., Lenhard, T., Foged, N.T., Werb, Z. et al. (2000) Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J. Cell Biol., 151, 879-889.
15. St-Jacques, B., Hammerschmidt, M. and McMahon, A.P. (1999) Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation. Genes Dev., 13, 2072-2086.
16. Long, F., Chung, U.I., Ohba, S., McMahon, J., Kronenberg, H.M. and McMahon, A.P. (2004) Ihh signaling is directly required for the osteoblast lineage in the endochondral skeleton. Development, 131, 1309-1318.
17. Kobayashi, T., Chung, U.I., Schipani, E., Starbuck, M., Karsenty, G., Katagiri, T., Goad, D.L., Lanske, B. and Kronenberg, H.M. (2002) PTHrP and Indian hedgehog control differentiation of growth plate chondrocytes at multiple steps. Development, 129, 2977-2986.
18. Lanske, B., Karaplis, A.C., Lee, K., Luz, A., Vortkamp, A., Pirro, A., Karperien, M., Defize, L.H., Ho, C., Mulligan, R.C. et al. (1996) PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth. Science, 273, 663-666.
19. Yoon, B.S. and Lyons, K.M. (2004) Multiple functions of BMPs in chondrogenesis. J. Cell Biochem., 93, 93-103.
20. Yu, K.O. (2007) The FGF ligand-receptor signaling system in chondrogenesis, osteogenesis and vascularization of the endochondral skeleton. International Congress Series, 1302, 67-78.
21. Delezoide, A.L., Benoist-Lasselin, C., Legeai-Mallet, L., Le Merrer, M., Munnich, A., Vekemans, M. and Bonaventure, J. (1998) Spatio-temporal expression of FGFR 1, 2 and 3 genes during human embryo-fetal ossification. Mech. Dev., 77, 19-30.
22. Xiao, L., Naganawa, T., Obugunde, E., Gronowicz, G., Ornitz, D.M., Coffin, J.D. and Hurley, M.M. (2004) Stat1 controls postnatal bone formation by regulating fibroblast growth factor signaling in osteoblasts. J. Biol. Chem., 279, 27743-27752.
23. Deng, C., Wynshaw-Boris, A., Zhou, F., Kuo, A. and Leder, P. (1996) Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell, 84, 911-921.
24. Chen, L., Adar, R., Yang, X., Monsonego, E.O., Li, C., Hauschka, P.V., Yayon, A. and Deng, C.X. (1999) Gly369Cys mutation in mouse FGFR3 causes achondroplasia by affecting both chondrogenesis and osteogenesis. J. Clin. Invest., 104, 1517-1525.
25. Su, N., Sun, Q., Li, C., Lu, X., Qi, H., Chen, S., Yang, J., Du, X., Zhao, L., He, Q. et al. (2010) Gain-of-function mutation in FGFR3 in mice leads to decreased bone mass by affecting both osteoblastogenesis and osteoclastogenesis. Hum. Mol. Genet., 19, 1199-1210.
26. Pannier, S., Mugniery, E., Jonquoy, A., Benoist-Lasselin, C., Odent, T., Jais, J.P., Munnich, A. and Legeai-Mallet, L. (2010) Delayed bone age due to a dual effect of FGFR3 mutation in Achondroplasia. Bone, 47, 905-915.
27. Pannier, S., Couloigner, V., Messaddeq, N., Elmaleh-Berges, M., Munnich, A., Romand, R. and Legeai-Mallet, L. (2009) Activating Fgfr3 Y367C mutation causes hearing loss and inner ear defect in a mouse model of chondrodysplasia. Biochim. Biophys. Acta, 1792, 140-147.
28. Jonquoy, A., Mugniery, E., Benoist-Lasselin, C., Kaci, N., Le Corre, L., Barbault, F., Girard, A.L., Le Merrer, Y., Busca, P., Schibler, L. et al. (2012) A novel tyrosine kinase inhibitor restores chondrocyte differentiation and promotes bone growth in a gain of function Fgfr3 mouse model. Hum. Mol. Genet, 21, 841-851.
29. Valverde-Franco, G., Liu, H., Davidson, D., Chai, S., Valderrama-Carvajal, H., Goltzman, D., Ornitz, D.M. and Henderson, J.E. (2004) Defective bone mineralization and osteopenia in young adult FGFR32/2 mice. Hum. Mol. Genet., 13, 271-284.
30. Eswarakumar, V.P. and Schlessinger, J. (2007) Skeletal overgrowth is mediated by deficiency in a specific isoform of fibroblast growth factor receptor 3. Proc. Natl Acad. Sci. USA, 104, 3937-3942.
31. Metzger, D., Clifford, J., Chiba, H. and Chambon, P. (1995) Conditional site-specific recombination in mammalian cells using a ligand-dependent chimeric Cre recombinase. Proc. Natl Acad. Sci. USA, 92, 6991-6995.
32. Ovchinnikov, D.A., Deng, J.M., Ogunrinu, G. and Behringer, R.R. (2000) Col2a1-directed expression of Cre recombinase in differentiating chondrocytes in transgenic mice. Genesis, 26, 145-146.
33. Dacquin, R., Starbuck, M., Schinke, T. and Karsenty, G. (2002) Mouse alpha1(I)-collagen promoter is the best known promoter to drive efficient Cre recombinase expression in osteoblast. Dev. Dyn., 224, 245-251.
34. Naski, M.C., Colvin, J.S., Coffin, J.D. and Ornitz, D.M. (1998) Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3. Development, 125, 4977-4988.
35. Chen, L., Li, C., Qiao, W., Xu, X. and Deng, C. (2001) A Ser(365)→Cys mutation of fibroblast growth factor receptor 3 in mouse downregulates Ihh/PTHrP signals and causes severe achondroplasia. Hum. Mol. Genet., 10, 457-465.
36. Iwata, T., Chen, L., Li, C., Ovchinnikov, D.A., Behringer, R.R., Francomano, C.A. and Deng, C.X. (2000) A neonatal lethal mutation in FGFR3 uncouples proliferation and differentiation of growth plate chondrocytes in embryos. Hum. Mol. Genet., 9, 1603-1613.
37. Legeai-Mallet, L., Benoist-Lasselin, C., Munnich, A. and Bonaventure, J. (2004) Overexpression of FGFR3, Stat1, Stat5 and p21Cip1 correlates with phenotypic severity and defective chondrocyte differentiation in FGFR3-related chondrodysplasias. Bone, 34, 26-36.
38. Wilkes, D., Rutland, P., Pulleyn, L.J., Reardon, W., Moss, C., Ellis, J.P., Winter, R.M. and Malcolm, S. (1996) A recurrent mutation, ala391glu, in the transmembrane region of FGFR3 causes Crouzon syndrome and acanthosis nigricans. J. Med. Genet., 33, 744-748.
39. Twigg, S.R., Healy, C., Babbs, C., Sharpe, J.A., Wood, W.G., Sharpe, P.T., Morriss-Kay, G.M. and Wilkie, A.O. (2009) Skeletal analysis of the Fgfr3(P244R) mouse, a genetic model for the Muenke craniosynostosis syndrome. Dev. Dyn., 238, 331-342.
40. Laurita, J., Koyama, E., Chin, B., Taylor, J.A., Lakin, G.E., Hankenson, K.D., Bartlett, S.P. and Nah, H.D. (2011) The Muenke syndrome mutation (FgfR3(P244R)) causes cranial base shortening associated with growth plate dysfunction and premature perichondrial ossification in murine basicranial synchondroses. Dev. Dyn., 240, 2584-2596.
41. Hojo, H., Ohba, S., Yano, F. and Chung, U.I. (2010) Coordination of chondrogenesis and osteogenesis by hypertrophic chondrocytes in endochondral bone development. J. Bone Miner. Metab., 28, 489-502.
42. Chung, U.I., Schipani, E., McMahon, A.P. and Kronenberg, H.M. (2001) Indian hedgehog couples chondrogenesis to osteogenesis in endochondral bone development. J. Clin. Invest., 107, 295-304.
43. Valverde-Franco, G., Binette, J.S., Li, W., Wang, H., Chai, S., Laflamme, F., Tran-Khanh, N., Quenneville, E., Meijers, T., Poole, A.R. et al. (2006) Defects in articular cartilage metabolism and early arthritis in fibroblast growth factor receptor 3 deficient mice. Hum. Mol. Genet., 15, 1783-1792.
44. Kobayashi, T., Lyons, K.M., McMahon, A.P. and Kronenberg, H.M. (2005) BMP signaling stimulates cellular differentiation at multiple steps during cartilage development. Proc. Natl Acad. Sci. USA, 102, 18023-18027.
45. Colnot, C., de la Fuente, L., Huang, S., Hu, D., Lu, C., St-Jacques, B. and Helms, J.A. (2005) Indian hedgehog synchronizes skeletal angiogenesis and perichondrial maturation with cartilage development. Development, 132, 1057-1067.
46. Weizmann, S., Tong, A., Reich, A., Genina, O., Yayon, A. and Monsonego-Ornan, E. (2005) FGF upregulates osteopontin in epiphyseal growth plate chondrocytes: implications for endochondral ossification. Matrix Biol., 24, 520-529.
47. Schiltz, C., Prouillet, C., Marty, C., Merciris, D., Collet, C., de Vernejoul, M.C. and Geoffroy, V. (2010) Bone loss induced by Runx2 over-expression in mice is blunted by osteoblastic over-expression of TIMP-1. J. Cell Physiol., 222, 219-229.
48. Parfitt, A.M., Drezner, M.K., Glorieux, F.H., Kanis, J.A., Malluche, H., Meunier, P.J., Ott, S.M.andRecker, R.R. (1987)Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMRHistomorphometry Nomenclature Committee. J. Bone Miner. Res., 2, 595-610.
49. Delezoide, A.L., Lasselin-Benoist, C., Legeai-Mallet, L., Brice, P., Senee, V., Yayon, A., Munnich, A., Vekemans, M. and Bonaventure, J. (1997) Abnormal FGFR 3 expression in cartilage of thanatophoric dysplasia fetuses. Hum. Mol. Genet., 6, 1899-1906.